Skip to content
Guavy Logo GUAVY
Sign up
Back to Guavy Wire
Stocks

Envestnet Boosts Stake in Biotech Leader Amgen

Guavy AI Editorial Team
Instruments
AMGN
Share

Envestnet Asset Management Inc., a financial services company, has increased its stake in Amgen Inc. (NASDAQ:AMGN), a biotechnology firm.

The acquisition of an additional 326,260 shares during the second quarter brought Envestnet's total holdings to 2,023,566 shares, representing a 19.2% increase in their position.

According to the company's SEC filing, Envestnet Asset Management Inc.'s stake in Amgen is now worth approximately $732,774,000 and accounts for about 0.37% of Amgen's outstanding stock.

More on Stocks

Stocks 1m ago

Microsoft Leaders Sued Over Rescue Deal for Gates and Hoffman

Stocks 2m ago

Nvidia Edges Out AMD as Top Chipmaker Amid AI Boom

Stocks 7m ago

$405M Visa Escrow Deposit Trims Class B Conversion Rates, Share Counts

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Guavy Logo GUAVY

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

Navigate

Markets

Resources

© 2026 Guavy Inc

Terms Privacy Policy